As of 2026-03-15, the Relative Valuation of Resmed Inc (RMD) is 346.32 USD. This relative valuation is based on P/E multiples. With the latest stock price at 230.84 USD, the upside of Resmed Inc based on Relative Valuation is 50.0%.
The range of the Relative Valuation is 286.21 - 492.44 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.5x - 48.3x | 36.1x |
| Forward P/E multiples | 26.2x - 41.2x | 29.7x |
| Fair Price | 286.21 - 492.44 | 346.32 |
| Upside | 24.0% - 113.3% | 50.0% |
| Date | P/E |
| 2026-03-13 | 22.63 |
| 2026-03-12 | 22.79 |
| 2026-03-11 | 23.55 |
| 2026-03-10 | 24.23 |
| 2026-03-09 | 24.80 |
| 2026-03-06 | 24.79 |
| 2026-03-05 | 25.03 |
| 2026-03-04 | 25.40 |
| 2026-03-03 | 25.32 |
| 2026-03-02 | 25.24 |
| 2026-02-27 | 25.12 |
| 2026-02-26 | 25.20 |
| 2026-02-25 | 24.76 |
| 2026-02-24 | 24.67 |
| 2026-02-23 | 25.57 |
| 2026-02-20 | 25.40 |
| 2026-02-19 | 25.13 |
| 2026-02-18 | 25.38 |
| 2026-02-17 | 25.08 |
| 2026-02-13 | 24.76 |
| 2026-02-12 | 24.09 |
| 2026-02-11 | 25.45 |
| 2026-02-10 | 25.84 |
| 2026-02-09 | 27.06 |
| 2026-02-06 | 26.63 |
| 2026-02-05 | 26.18 |
| 2026-02-04 | 25.79 |
| 2026-02-03 | 24.65 |
| 2026-02-02 | 24.98 |
| 2026-01-30 | 25.33 |
| 2026-01-29 | 25.26 |
| 2026-01-28 | 25.27 |
| 2026-01-27 | 25.05 |
| 2026-01-26 | 25.05 |
| 2026-01-23 | 24.74 |
| 2026-01-22 | 25.04 |
| 2026-01-21 | 25.42 |
| 2026-01-20 | 24.82 |
| 2026-01-16 | 25.25 |
| 2026-01-15 | 25.56 |
| 2026-01-14 | 25.44 |
| 2026-01-13 | 24.97 |
| 2026-01-12 | 25.28 |
| 2026-01-09 | 24.75 |
| 2026-01-08 | 24.60 |
| 2026-01-07 | 24.34 |
| 2026-01-06 | 24.43 |
| 2026-01-05 | 24.06 |
| 2026-01-02 | 24.00 |
| 2025-12-31 | 23.62 |